Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

api image memantine-hydrochloride top

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Memantine Hcl Manufacturers in India Suppliers Memantine Hcl Exporters Distributors Memantine Hcl api active pharmaceuticals ingredients Memantine Hcl manufacturers Side Effects bulk drugs raw material Memantine Hcl companies Side Effects Importers Memantine Hcl Memantine Hcl Exporters Memantine Hcl exporters FDA Memantine Hcl DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Memantine Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Memantine Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Memantine Hydrochloride active pharmaceutical ingredients Memantine Hydrochloride committee active pharmaceutical ingredients manufacturer Memantine Hydrochloride Active Pharmaceutical Ingredients manufacturer Memantine Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Memantine Hcl, Memantine Hcl manufacturer India, Memantine Hcl product, Memantine Hcl products, Api preparation, Certificate of Analysis API manufacturer product, Memantine Hcl anti ulcer product, Certificate of Origin COA Memantine Hcl COS Memantine Hcl, pharmaceutical generic, pharmaceutical drug, medical, Memantine Hcl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Memantine Hcl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Memantine Hcl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Memantine Hcl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Memantine Hcl ingredients, api, HIV Memantine Hcl, tablets, capsules, syrup & protein Memantine Hcl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Memantine Hcl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Memantine Hcl WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

taj pharma api image Memantine Hcl
















 

 





 

 

HOME >> API >> API List 2 >> Memantine Hcl >> Drug Description

Memantine hydrochloride

DRUG DESCRIPTION
Memantine Hcl CAS Number 41100-52-1

Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system by blocking NMDA glutamate receptors. Memantine was first synthesized and patented by Eli Lilly and Company in 1968 (as cited in the Merck Index), and then developed by Merz in collaboration with Neurobiological Technologies

The tablets also contain the following inactive ingredients: microcrystalline cellulose/colloidal silicon dioxide, talc, croscarmellose sodium, and magnesium stearate. In addition the following inactive ingredients are also present as components of the film coat: hypromellose, titanium dioxide, polyethylene glycol 400, FD&C yellow #6 and FD&C blue #2 (5 mg tablets), and hypromellose, titanium dioxide, macrogol/polyethylene glycol 400 and iron oxide black (10 mg tablets). Namenda oral solution contains memantine hydrochloride in a strength equivalent to 2 mg of memantine hydrochloride in each mL. The oral solution also contains the following inactive ingredients: sorbitol solution (70%), methyl paraben, propylparaben, propylene glycol, glycerin, natural peppermint flavor #104, citric acid, sodium citrate, and purified water.

Memantine is an oral medication for treating patients with Alzheimer's disease. Other medications used for Alzheimer's disease affect acetylcholine, one of the neurotransmitter chemicals that nerve cells in the brain use to communicate with one another. These drugs - galantamine (Razadyne - formerly known as Reminyl), donezepil (Aricept), rivastigmine (Exelon), and tacrine (Cognex)-- inhibit the enzyme acetylcholinesterase that destroys acetylcholine and thereby increases the effects of acetylcholine. Memantine's effects are independent of acetylcholine and acetylcholinesterase.

Glutamate is the main excitatory neurotransmitter in the brain. It is believed that too much stimulation of nerve cells by glutamate may be responsible for the degeneration of nerves that occurs in some neurological diseases such as Alzheimer's disease. Like other neurotransmitters, glutamate is produced and released by nerve cells in the brain. The released glutamate then travels to nearby nerve cells where it attaches to a receptor on the surface of the cells called the N-methyl-D-aspartate (NMDA) receptor. Memantine blocks the receptor and thereby decreases the effects of glutamate. It is thought that by blocking the NMDA receptor and the effects of glutamate, memantine may protect nerve cells from excess stimulation by glutamate

Information Associated with Product:
DRUG DESCRIPTION >>
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Memantine Hcl

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.